Loading...
Loading...
Application UK00004348293 · Application Published
| Application Number | UK00004348293 |
| Status | Application Published |
| Owner | Lite Strategy, Inc. |
| Filed | 2026-03-03 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
LITE STRATEGY has a current status of Application Published.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Pharmaceuticals for use in the treatment of oncological disorders, neurological disorders, and immune-related disorders.
Financial services; financial services, namely, providing cryptocurrency treasury reserve services; investment of funds for others in the field of cryptocurrency and cryptocurrency mining; financial management services and financial advisory services in the fields of cryptocurrency and cryptocurrency mining.
Pharmaceutical research and development.
'LITE STRATEGY' is a application published trademark on the UK IPO register, owned by Lite Strategy, Inc.. The application (UK00004348293) was filed on 3 March 2026.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 36 (insurance & financial services); Class 42 (scientific, IT & design services).
The trademark is represented by Morgan, Lewis & Bockius UK LLP.
UK trademark UK00004348293 for the mark 'LITE STRATEGY' in Class 5, 36, 42 is recorded on the UK IPO register as owned by Lite Strategy, Inc.. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
No — the UK IPO records the status of UK trademark UK00004348293 for the mark 'LITE STRATEGY' as application published.
UK trademark UK00004348293 for the mark 'LITE STRATEGY' is recorded in Class 5 (pharmaceuticals & medical preparations); Class 36 (insurance & financial services); Class 42 (scientific, IT & design services). The filed specification reads: Class 5: Pharmaceuticals for use in the treatment of oncological disorders, neurological disorders, and immune-related disorders. | Class 36: Financial services; financial services, namely, providing cryptocurrency treasury reserve services; investment of funds for others in the field of cryptocurrency and cryptocur…
UK trademark UK00004348293 for the mark 'LITE STRATEGY' was filed at the UK IPO on 3 March 2026.
The UK IPO first published / advertised UK trademark UK00004348293 for the mark 'LITE STRATEGY' on 20 March 2026.
Morgan, Lewis & Bockius UK LLP is listed as the attorney / representative of record for UK trademark UK00004348293 for the mark 'LITE STRATEGY' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Trademarks matching "LITE STRATEGY" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
| Mark | Ref | Status | Filed |
|---|---|---|---|
| LITE STRATEGYSame applicant | 99504971 | 630 | 2025-11-19 |
| Mark | Ref | Status | Filed |
|---|---|---|---|
| LITE STRATEGYSame applicant | 2632184 | published | 2026-03-03 |
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
Australian trademark data is supplied by IP Australia (via IPGOD / IP RAPID) under the Creative Commons Attribution 4.0 International licence.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.